Prescription-free consultation: A cross-sectional study in general practice

IF 2.2 4区 医学 Q3 PHARMACOLOGY & PHARMACY Therapie Pub Date : 2024-05-01 DOI:10.1016/j.therap.2023.07.003
Amélie Richard , Élodie Charuel , Sébastien Cambier , Manon Turpin , Bruno Baudin , José-Philippe Moreno , Hélène Vaillant-Roussel
{"title":"Prescription-free consultation: A cross-sectional study in general practice","authors":"Amélie Richard ,&nbsp;Élodie Charuel ,&nbsp;Sébastien Cambier ,&nbsp;Manon Turpin ,&nbsp;Bruno Baudin ,&nbsp;José-Philippe Moreno ,&nbsp;Hélène Vaillant-Roussel","doi":"10.1016/j.therap.2023.07.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>In 2005, 10% of consultations in France ended without a prescription. In 2019, a review of the literature found 30 to 70% of prescription-free consultations in Northern Europe and 10 to 22% in Southern Europe and underlined the scarcity of quantitative data. Different factors contribute to this heterogeneity, such as product availability and status, modes of management, distribution channels, clinical practice recommendations, public policies targeting certain classes, etc. The main objective of our study was to quantify the rate of prescription-free consultations in general practice in France in 2021. The secondary objective was to characterize prescription-free consultations and analyze their determinants.</p></div><div><h3>Methods</h3><p>This was a quantitative observational study conducted using self-questionnaires among patients in medical practices in Auvergne.</p></div><div><h3>Results</h3><p>Out of 540 questionnaires, the rate of prescription-free consultations was 24% (95% CI [20.11–27.41]). Prescription-free consultations were for prevention, administrative problems, and gestures. The limiting factors are “feeling a need for a medication” (OR<!--> <!-->=<!--> <!-->0,006), “not knowing if a medication is needed” (OR<!--> <!-->=<!--> <!-->0.11) and “consultations for acute reasons” (OR<!--> <!-->=<!--> <!-->0.33).</p></div><div><h3>Conclusion</h3><p>Acute consultations limit prescription-free consultations. General practitioners (GPs) probably overestimate patients’ expectation of drug prescription. The French GP must be supported in their decision to not prescribe drugs. This is a long-term investment of time, to educate patients and avoid new consultations for acute reasons. A tool to help doctors manage non-prescription during acute consultations will be created in a future study in France.</p></div>","PeriodicalId":23147,"journal":{"name":"Therapie","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S004059572300104X/pdfft?md5=f2b8af16cae065d0d1d5837deedecdfb&pid=1-s2.0-S004059572300104X-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapie","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S004059572300104X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

In 2005, 10% of consultations in France ended without a prescription. In 2019, a review of the literature found 30 to 70% of prescription-free consultations in Northern Europe and 10 to 22% in Southern Europe and underlined the scarcity of quantitative data. Different factors contribute to this heterogeneity, such as product availability and status, modes of management, distribution channels, clinical practice recommendations, public policies targeting certain classes, etc. The main objective of our study was to quantify the rate of prescription-free consultations in general practice in France in 2021. The secondary objective was to characterize prescription-free consultations and analyze their determinants.

Methods

This was a quantitative observational study conducted using self-questionnaires among patients in medical practices in Auvergne.

Results

Out of 540 questionnaires, the rate of prescription-free consultations was 24% (95% CI [20.11–27.41]). Prescription-free consultations were for prevention, administrative problems, and gestures. The limiting factors are “feeling a need for a medication” (OR = 0,006), “not knowing if a medication is needed” (OR = 0.11) and “consultations for acute reasons” (OR = 0.33).

Conclusion

Acute consultations limit prescription-free consultations. General practitioners (GPs) probably overestimate patients’ expectation of drug prescription. The French GP must be supported in their decision to not prescribe drugs. This is a long-term investment of time, to educate patients and avoid new consultations for acute reasons. A tool to help doctors manage non-prescription during acute consultations will be created in a future study in France.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
免处方咨询:全科医生横断面研究。
目的:2005 年,法国有 10%的就诊无需处方。2019 年,一项文献综述发现,北欧有 30% 至 70% 的问诊无需处方,南欧则为 10% 至 22%,并强调了定量数据的稀缺性。造成这种异质性的因素多种多样,如产品供应和状况、管理模式、分销渠道、临床实践建议、针对某些类别的公共政策等。我们研究的主要目的是量化 2021 年法国全科免处方就诊率。次要目标是描述免处方就诊的特点并分析其决定因素:方法:这是一项定量观察研究,采用自我问卷调查的方式,调查对象为奥弗涅省医疗机构的患者:在 540 份问卷中,免处方就诊率为 24%(95% CI [20.11-27.41])。免处方就诊的原因包括预防、行政问题和手势。限制因素是 "感觉需要用药"(OR=0,006)、"不知道是否需要用药"(OR=0.11)和 "因急性病就诊"(OR=0.33):结论:急性就诊限制了无处方就诊。全科医生可能高估了患者对药物处方的期望。法国全科医生在决定不开药时必须得到支持。这是一项长期的时间投资,既要教育患者,又要避免因急性病而重新就诊。未来在法国进行的一项研究将开发一种工具,帮助医生在急性就诊期间管理非处方药。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Therapie
Therapie 医学-药学
CiteScore
3.50
自引率
7.70%
发文量
132
审稿时长
57 days
期刊介绍: Thérapie is a peer-reviewed journal devoted to Clinical Pharmacology, Therapeutics, Pharmacokinetics, Pharmacovigilance, Addictovigilance, Social Pharmacology, Pharmacoepidemiology, Pharmacoeconomics and Evidence-Based-Medicine. Thérapie publishes in French or in English original articles, general reviews, letters to the editor reporting original findings, correspondence relating to articles or letters published in the Journal, short articles, editorials on up-to-date topics, Pharmacovigilance or Addictovigilance reports that follow the French "guidelines" concerning good practice in pharmacovigilance publications. The journal also publishes thematic issues on topical subject. The journal is indexed in the main international data bases and notably in: Biosis Previews/Biological Abstracts, Embase/Excerpta Medica, Medline/Index Medicus, Science Citation Index.
期刊最新文献
Elexacaftor/tezacaftor/ivacaftor induced liver enzymes abnormalities in breastfed infants: A series of 3 cases. Retinal vascular occlusion after COVID-19 vaccination: Analysis of the French pharmacovigilance database. Impact of new drug releases on heart failure management and hospitalizations in France: A repeated cross-sectional study between 2014 and 2023. [Use of a pharmaceutical decision support system in the valuation of hospital stays: Evaluation through 3 examples in collaboration with the department of medical information]. Exposure assessment of titanium dioxide via drugs available on the French market: A nationwide descriptive study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1